Wird geladen...
Conversion Ratio between Botox(®), Dysport(®), and Xeomin(®) in Clinical Practice
Botulinum neurotoxin has revolutionized the treatment of spasticity and is now administered worldwide. There are currently three leading botulinum neurotoxin type A products available in the Western Hemisphere: onabotulinum toxin-A (ONA) Botox(®), abobotulinum toxin-A (ABO), Dysport(®), and incobotu...
Gespeichert in:
| Veröffentlicht in: | Toxins (Basel) |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4810210/ https://ncbi.nlm.nih.gov/pubmed/26959061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins8030065 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|